A new lease of life: How India’s first CAR-T cell therapy is helping patients battle cancer.
The ImmunoACT team that worked on India's first approved CAR-T therapy NexCAR 19; image courtesy: ImmunoACT
Synopsis
NexCAR 19, India’s first cell therapy to treat a specific form of blood cancer, is showing encouraging results. Now listed at 40 hospitals across the country, its indigenous maker, ImmunoACT, is driving a medical revolution. Can the battle against the emperor of all maladies be won?
Have you heard of Emily Whitehead or Thejna John? Well, both are cancer patients once ‘written off’ by doctors. Whitehead, a resident of Philadelphia, US, was diagnosed with acute lymphoblastic leukemia (ALL) in May 2010. She was only five years old. The disease had become resistant to treatment, and it was expected to claim her life within a few weeks. John, a 27-year-old from Kerala’s Kollam district, underwent bone marrow transplant after
Refer & Earn
Get Unlimited Access to The Economic Times
